NCI-MATCH aimed to determine whether certain cancer therapies could be used more broadly. If a medicine is effective against one type of cancer with a specific mutation, the trial asked, could it treat other cancers with the same mutation? After the eight-year trial, scientists say an answer is coming into view
Tags:
Warm, sunny weather in summer and fall is perfect for outdoor celebrations. Independence Day, Labor Day, family reunions, parades, cookouts, birthday parties—these are all occasions for which folks gather together to enjoy each other’s company, eat great food, and often top off the event with fireworks.
Few things say “summer” like splashing around in water, leaping off a diving board, and soaking up the sun. We’ve all heard the tried-and-true advice for swimming: don’t run near water, don’t swim after eating, don’t do horseplay. But there are some lesser-known ways to reduce your chances of having an accident.
Early in the COVID-19 pandemic, before vaccines were available and while SARS-CoV-2 was wreaking havoc worldwide, Barry O’Keefe, Ph.D., and longtime collaborators in Brazil and Spain pooled their knowledge and resources to study cyanovirin-N (CV-N), a protein from cyanobacteria, photosynthetic bacteria commonly known as blue-green algae. O’Keefe had a hunch it could be developed to fight the spread of SARS-CoV-2.
Former Werner H. Kirsten (WHK) Student Intern Program participant Lea Jih-Vieira followed a narrow path of interest and discovered a plethora of possibilities.